205 related articles for article (PubMed ID: 33711391)
1. The soluble guanylate cyclase stimulator, 1-nitro-2-phenylethane, reverses monocrotaline-induced pulmonary arterial hypertension in rats.
Gonzaga-Costa K; Roque CR; Vasconcelos-Silva AA; Sousa-Brito HL; Martins CS; Caetano-Souza MM; Duarte GP; da Silva JKR; Borges RS; Dos Santos AA; Magalhães PJC; Lahlou S
Life Sci; 2021 Jun; 275():119334. PubMed ID: 33711391
[TBL] [Abstract][Full Text] [Related]
2. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
[TBL] [Abstract][Full Text] [Related]
3. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
[No Abstract] [Full Text] [Related]
4. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
5. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
[TBL] [Abstract][Full Text] [Related]
6. Early Intervention of Tongxinluo () on Right Ventricular Function Assessed by Echocardiography in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline.
Gao L; Li SD; Zhang Y; Liu Y; Yang MH
Chin J Integr Med; 2020 Dec; 26(12):913-920. PubMed ID: 32418178
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
8. BK
Ferraz AP; Seara FAC; Baptista EF; Barenco TS; Sottani TBB; Souza NSC; Domingos AE; Barbosa RAQ; Takiya CM; Couto MT; Resende GO; Campos de Carvalho AC; Ponte CG; Nascimento JHM
Cardiovasc Drugs Ther; 2021 Aug; 35(4):719-732. PubMed ID: 33245463
[TBL] [Abstract][Full Text] [Related]
9. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.
Zhao H; Wang Y; Zhang X; Guo Y; Wang X
Toxicol Appl Pharmacol; 2020 Jan; 386():114827. PubMed ID: 31734320
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
[TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
[TBL] [Abstract][Full Text] [Related]
12. The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity.
Zimmer A; Teixeira RB; Constantin RL; Campos-Carraro C; Aparicio Cordero EA; Ortiz VD; Donatti L; Gonzalez E; Bahr AC; Visioli F; Baldo G; Luz de Castro A; Araujo AS; Belló-Klein A
Eur J Pharmacol; 2021 Jan; 891():173699. PubMed ID: 33160936
[TBL] [Abstract][Full Text] [Related]
13. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
[TBL] [Abstract][Full Text] [Related]
14. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
15. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
Alencar AK; Pereira SL; da Silva FE; Mendes LV; Cunha Vdo M; Lima LM; Montagnoli TL; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; Sant'anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Int J Cardiol; 2014 May; 173(2):154-62. PubMed ID: 24630383
[TBL] [Abstract][Full Text] [Related]
16. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
[TBL] [Abstract][Full Text] [Related]
18. Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
Wang Y; Tian W; Xiu C; Yan M; Wang S; Mei Y
Clin Rheumatol; 2019 Jan; 38(1):29-35. PubMed ID: 29362961
[TBL] [Abstract][Full Text] [Related]
19. Bucindolol attenuates the vascular remodeling of pulmonary arteries by modulating the expression of the endothelin-1 A receptor in rats with pulmonary arterial hypertension.
de Lima-Seolin BG; Hennemann MM; Fernandes RO; Colombo R; Bonetto JHP; Teixeira RB; Khaper N; Godoy AEG; Litvin IE; Sander da Rosa Araujo A; Schenkel PC; Belló-Klein A
Biomed Pharmacother; 2018 Mar; 99():704-714. PubMed ID: 29710468
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats.
Alencar AK; Pereira SL; Montagnoli TL; Maia RC; Kümmerle AE; Landgraf SS; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Br J Pharmacol; 2013 Jul; 169(5):953-62. PubMed ID: 23530610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
